Ending COVID-19: from Ideas to Collective Action
Hear the progress and partnerships made by pharma, government, academia and investors and how you can pitch in too
Future of AI in Medical Imaging
Aiding healthcare professionals in the diagnosis and prevention of disease through machine learning applications for medical imaging
Investing in the Future of Healthcare & Medicine
VCs give their take on investing during COVID and how they’re navigating the new, unique demand for digital health solutions
Therapies for Alzheimer's, Parkinson's, LBD & other NBD: Where we are and what lies ahead
Renowned experts discuss causes of neurodegeneration & whether approved or emerging drugs, gene/cell therapies, physical therapy or stimuli can attenuate disease progression and/or improve quality of life
Designing for the Future of Digital Health
The science, psychology, design and evaluation of motivating healthy behaviours on digital health platforms
The New Frontiers of Psychedelic Medicine
The science, research and investment of psychedelic medicine for mental health
Future of Business Model Innovation in Healthcare
Innovating business models to take advantage of technologies to improve and impact how patients access and pay for care to maintain their health
-
5:30 am - 6:00 am (PT)
Preview videos to match for 1:1 mixers
-
6:00 am - 6:45 am (PT)
Introduction & Fireside Chat: From Science to Startup
-
6:45 am - 7:30 am (PT)
Ending COVID-19: from Ideas to Collective Action
-
7:30 am - 8:00 am (PT)
Group mixer - Hop in and out of breakout rooms
-
8:00 am - 9:00 am (PT)
*** The following three sessions will be conducted simultaneously. ***
Investing in the Future of Healthcare & Medicine Entrepreneurship
-
8:00 am - 9:00 am (PT)
Future of AI in Medical Imaging Technology
-
David Paik Sirona Chief Scientific Officer
-
Carla Leibowitz Paige Chief BD Officer
-
John Axerio-Cilies Arterys CEO & Co-Founder
-
Torrey Smith Endiatx Co-Founder & CEO
-
Michael Abramoff Digital Diagnostics, Inc Founder and Executive Chairman
-
Darwin Ling Good AI Capital Founder & General Partner moderator
-
-
8:00 am - 9:00 am (PT)
Therapies for Alzheimer's, Parkinson's, LBD & other NBD: Where we are and what lies ahead Medicine
-
Adam Boxer UCSF Memory & Aging Center Director Clinical Neurology
-
Ted Dawson Johns Hopkins University School of Medicine Director Institute for Cell Engineering
-
Edmond Teng Genentech Lead Medical Director
-
Joseph Lewcock Denali Therapeutics Chief Scientific Officer & Head of Discovery
-
Anirvan Ghosh Unity Biotechnology CEO moderator
-
Julide Bilen JD Brainscience Founder moderator
-
Daniel L. Flamm JD Brainscience CEO Microtechnology Law & Analysis moderator
-
-
9:00 am - 9:30 am (PT)
1:1 mixer - You'll be matched with another attendee for six-minute 1-on-1s based upon your answers to the pre-event survey
-
9:30 am - 10:30 am (PT)
*** The following three sessions will be conducted simultaneously. ***
Designing for the Future of Digital Health Technology
-
9:30 am - 10:30 am (PT)
The New Frontiers of Psychedelic Medicine Medicine
-
9:30 am - 10:30 am (PT)
Future of Business Model Innovation in Healthcare Entrepreneurship
-
10:30 am - 11:00 am (PT)
Group mixer - Hop in and out of breakout rooms
-
11:00 am - 11:30 am (PT)
1:1 mixer - You'll be matched with another attendee for six-minute 1-on-1s based upon your answers to the pre-event survey
